A causal role for TRESK loss of function in migraine mechanisms

The two-pore potassium channel TRESK is a potential drug target in pain and migraine. Pettingill et al. show that the F139WfsX2 mutation causes TRESK loss of function and hyperexcitability in nociceptors derived from iPSCs of patients with migraine. Cloxyquin, a TRESK activator, reverses migraine-relevant phenotypes in vitro and in vivo.

[1]  M. Z. Cader,et al.  The Role of TRESK in Discrete Sensory Neuron Populations and Somatosensory Processing , 2019, Front. Mol. Neurosci..

[2]  A. Dhaka,et al.  TRESK K+ Channel Activity Regulates Trigeminal Nociception and Headache , 2019, eNeuro.

[3]  X. Gasull,et al.  Migraine-Associated TRESK Mutations Increase Neuronal Excitability through Alternative Translation Initiation and Inhibition of TREK , 2019, Neuron.

[4]  D. Nyholt.  Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families , 2018, Neuron.

[5]  D. Strachan,et al.  Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families , 2018, Neuron.

[6]  Palotie Aarno,et al.  1,589家系における片頭痛の家族性凝集に寄与する一般的な変異負荷【JST・京大機械翻訳】 , 2018 .

[7]  Michael Q. Zhang,et al.  Comparative transcriptome profiling of the human and mouse dorsal root ganglia: An RNA-seq-based resource for pain and sensory neuroscience research , 2017, bioRxiv.

[8]  M. Lengyel,et al.  Selective and state‐dependent activation of TRESK (K2P18.1) background potassium channel by cloxyquin , 2017, British journal of pharmacology.

[9]  D. MacArthur,et al.  Using high-resolution variant frequencies to empower clinical genome interpretation , 2016, Genetics in Medicine.

[10]  A. Charles,et al.  The effects of acute and preventive migraine therapies in a mouse model of chronic migraine , 2016, Cephalalgia : an international journal of headache.

[11]  Alex Gutteridge,et al.  Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia , 2016, Science Translational Medicine.

[12]  B. L. de Groot,et al.  A Non-canonical Voltage-Sensing Mechanism Controls Gating in K2P K+ Channels , 2016, Cell.

[13]  Chris P. Ponting,et al.  Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics , 2016, Human molecular genetics.

[14]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[15]  J. Tajti,et al.  Utility of different outcome measures for the nitroglycerin model of migraine in mice. , 2016, Journal of pharmacological and toxicological methods.

[16]  Jack R. Collins,et al.  AVIA v2.0: annotation, visualization and impact analysis of genomic variants and genes , 2015, Bioinform..

[17]  Beiyan Zou,et al.  Identification of novel small molecule modulators of K2P18.1 two-pore potassium channel. , 2014, European journal of pharmacology.

[18]  Ping Liu,et al.  Nonmigraine-associated TRESK K+ channel variant C110R does not increase the excitability of trigeminal ganglion neurons. , 2014, Journal of neurophysiology.

[19]  Daniel J. Gaffney,et al.  Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells , 2014, PLoS genetics.

[20]  Richard Wade-Martins,et al.  Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons , 2014, PloS one.

[21]  A. Charles,et al.  Characterization of a novel model of chronic migraine , 2014, PAIN®.

[22]  C. Kettleborough,et al.  Cloxyquin (5-Chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK. , 2013, Biochemical and biophysical research communications.

[23]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[24]  Ping Liu,et al.  Functional Analysis of a Migraine-Associated TRESK K+ Channel Mutation , 2013, The Journal of Neuroscience.

[25]  Cheng-xiang Yang,et al.  Intrathecal TRESK gene recombinant adenovirus attenuates spared nerve injury-induced neuropathic pain in rats , 2013, Neuroreport.

[26]  M. Z. Cader,et al.  Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK. , 2013, Biochemical and biophysical research communications.

[27]  M. Zameel Cader.  The molecular pathogenesis of migraine: new developments and opportunities. , 2013, Human molecular genetics.

[28]  Timothy J Shafer,et al.  Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set. , 2012, Neurotoxicology.

[29]  G. Rouleau,et al.  Identification of Novel Genes Involved in Migraine , 2012, Headache.

[30]  S. Shi,et al.  Combined small molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors , 2012, Nature Biotechnology.

[31]  L. Griffiths,et al.  Functional analysis of missense variants in the TRESK (KCNK18) K+ channel , 2012, Scientific Reports.

[32]  J. Serra,et al.  TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury , 2011, Molecular pain.

[33]  Marie-Pierre Dubé,et al.  A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura , 2010, Nature Medicine.

[34]  Yaron M Sigal,et al.  Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels , 2008, Nature Neuroscience.

[35]  E. Wischmeyer,et al.  TRESK two‐pore‐domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones , 2007, The Journal of physiology.

[36]  Joseph F. Cotten,et al.  Species-Specific Differences in Response to Anesthetics and Other Modulators by the K2P Channel TRESK , 2005, Anesthesia and analgesia.

[37]  A. M. Rush,et al.  Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. , 2005, Brain : a journal of neurology.

[38]  Z. Tóth,et al.  The Two-pore Domain K+ Channel, TRESK, Is Activated by the Cytoplasmic Calcium Signal through Calcineurin* , 2004, Journal of Biological Chemistry.

[39]  A. F. Stewart,et al.  High-throughput engineering of the mouse genome coupled with high-resolution expression analysis , 2003, Nature Biotechnology.

[40]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[41]  W. Dixon,et al.  Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.